Noticias de RZLT_US

Noticias del mercado

Últimas noticias sobre RZLT_US — 116 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: RZLT_US ✕ 116 resultados
09/04/2026 RZLT_US — sonla.gov.vn
RZLT Q2 2026 Earnings: Rezolute Inc. posts wider-than-expected loss, reports no revenue
09/04/2026 RZLT_US — haiphong.gov.vn
RZLT Q2 2026 Earnings: Rezolute Inc. posts wider-than-expected loss, reports no revenue
31/03/2026 RZLT_US — Stock Titan
Rezolute (RZLT) CFO adds 10,000 shares in open-market purchase
31/03/2026 RZLT_US — Investing.com
Rezolute CFO Evans Daron buys $28,500 in RZLT stock
30/03/2026 RZLT_US — Seeking Alpha
Rezolute: Sell Rating Despite FDA Feedback From Type B Meeting For Ersodetug (NASDAQ:RZLT)
26/03/2026 RZLT_US — Stock Titan
Vanguard realigns reporting; no beneficial stake in Rezolute (RZLT)
25/03/2026 RZLT_US — Investing.com
Citizens reiterates Market Perform on Rezolute stock after FDA update
25/03/2026 RZLT_US — Yahoo Finance
Rezolute Stock Gains After FDA Meeting on Ersodetug Program Update
25/03/2026 RZLT_US — Eastern Progress
Rezolute Stock Gains After FDA Meeting on Ersodetug Program Update
25/03/2026 RZLT_US — Investing.com
Wedbush upgrades Rezolute stock rating on FDA feedback
25/03/2026 RZLT_US — Investing.com
Cantor Fitzgerald reiterates Neutral on Rezolute stock after FDA meeting
25/03/2026 RZLT_US — timothysykes.com
Rezolute Shares Rise After FDA Signals Hope for Treatment Approval
25/03/2026 RZLT_US — GuruFocus
Rezolute (RZLT) Gains Upgrade Following Positive FDA Meeting
25/03/2026 RZLT_US — StocksToTrade
Rezolute’s Shares Soar Despite Initial Obstacles in Trial Data
25/03/2026 RZLT_US — GuruFocus
RZLT: Wedbush Upgrades Rezolute with Raised Price Target | RZLT Stock News
24/03/2026 RZLT_US — BioSpace
Rezolute Lauds ‘Unusual’ FDA Feedback Supportive of Path Forward for Hypoglycemia Drug
24/03/2026 RZLT_US — Seeking Alpha
Rezolute gains after positive FDA meeting (RZLT:NASDAQ)
24/03/2026 RZLT_US — Investing.com
Rezolute to submit sunRIZE trial data to FDA for review
24/03/2026 RZLT_US — Benzinga
FDA Review Puts Rezolute's Genetic Disorder Drug Path In Question - Rezolute (NASDAQ:RZLT)
24/03/2026 RZLT_US — TradingView
Rezolute says FDA invited submission of sunRIZE data after Type B meeting; review could inform marketing path

Página 5 de 6

keyboard_arrow_up